taxonomy (1)
protein (1)
source (1)
structure (36)
composition (46)
disease (1)
reference (1)
site (3)
peptide (2)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- CHO (CVCL_0213)
Source
- N-Linked / Complex / Structure 1850
- N-Linked / Complex / Structure 9347
- N-Linked / Complex / Structure 1497
- N-Linked / Complex / Structure 2643
- N-Linked / Complex / Structure 2719
- N-Linked / Complex / Structure 9792
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9689
- N-Linked / Complex / Structure 9780
- N-Linked / Complex / Structure 9702
- N-Linked / Complex / Structure 9555
- N-Linked / Complex / Structure 9663
- N-Linked / Complex / Structure 10087
- N-Linked / Complex / Structure 9815
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)[Gal(?1-?)GlcNAc(?1-?)]Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)[Gal(?1-?)GlcNAc(?1-?)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 10099
- N-Linked / Complex / Structure 9998
- N-Linked / Complex / Structure 10071
- N-Linked / High-Mannose / Structure 10092
- O-Linked / Core 1 / Gal(b1-3)GalNAc
- O-Linked / Core 1 / Structure 9312
- O-Linked / Core 1 / Gal(b1-3)[Neu5Ac(?2-?)]GalNAc(a1-
- O-Linked / Core 1 / NeuAc(?2-?)Gal(b1-3)GalNAc
- O-Linked / Core 1 / Neu5Ac(?2-?)Gal(b1-3)[Neu5Ac(?2-?)]GalNAc(a1-
- O-Linked / Core 2 / Structure 10074
- O-Linked / Core 2 / Structure 10101
- O-Linked / Core 2 / Structure 10111
- O-Linked / Core 2 / Structure 10079
- O-Linked / Core 2 / Structure 9364
- O-Linked / Core 2 / Structure 10075
- O-Linked / Core 2 / Structure 9504
- O-Linked / Core 2 / Structure 10081
- O-Linked / Core 2 / Structure 10112
- O-Linked / Core 2 / NeuAc(?2-?)Gal(?1-?)GlcNAc(b1-6)[NeuAc(?2-?)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Structure 10098
- O-Linked / Core 2 / Structure 10100
Reported structure
- HexNAc:1 NeuAc:1 (avg mass : 512.4682 )
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )
- Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
- Hex:1 HexNAc:2 NeuAc:1 (avg mass : 877.8056 )
- Hex:1 HexNAc:3 NeuAc:1 (avg mass : 1081.0006 )
- Hex:1 HexNAc:3 NeuAc:1 Su:1 (avg mass : 1161.0648 )
- Hex:1 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1227.1436 )
- Hex:2 HexNAc:2 (avg mass : 748.6901 )
- Hex:2 HexNAc:2 Su:1 (avg mass : 828.7543 )
- Hex:2 HexNAc:2 NeuAc:1 (avg mass : 1039.948 )
- Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )
- Hex:2 HexNAc:2 NeuAc:2 Su:1 (avg mass : 1411.2701 )
- Hex:2 HexNAc:2 dHex:1 NeuAc:1 (avg mass : 1186.091 )
- Hex:2 HexNAc:2 dHex:2 NeuAc:1 (avg mass : 1332.234 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:6 dHex:1 (avg mass : 1869.7555 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:5 HexNAc:2 Ph:1 (avg mass : 1315.0972 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:3 (avg mass : 2283.1313 )
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:6 HexNAc:2 Ph:1 (avg mass : 1477.2396 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:6 HexNAc:7 (avg mass : 2413.2347 )
- Hex:6 HexNAc:7 dHex:1 (avg mass : 2559.3777 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2809.583 )
- Hex:7 HexNAc:7 dHex:1 (avg mass : 2721.5201 )
- Hex:8 HexNAc:7 dHex:1 (avg mass : 2883.6625 )
- Hex:8 HexNAc:8 dHex:1 (avg mass : 3086.8575 )
- Hex:9 HexNAc:8 dHex:1 (avg mass : 3248.9999 )
- Hex:10 HexNAc:9 dHex:1 (avg mass : 3614.3373 )
Composition
- COVID-19 (DOID:0080600)
Disease
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- FPNIT (5aa)
- GEVFNATR (8aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1260.1705)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 1315.0972)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- N-Linked / Complex
(avg mass : 1422.3129)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 1463.3655)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 1625.5079)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 1666.5605)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 1787.6503)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 1828.7029)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 1990.8453)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 2031.8979)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 2152.9877)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 2194.0403)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 2356.1827)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 2444.2456)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- N-Linked / Complex
(avg mass : 2518.3251)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 2721.5201)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- N-Linked / Complex
(avg mass : 2883.6625)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- N-Linked / Complex
(avg mass : 3248.9999)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- N-Linked / High-Mannose
(avg mass : 1477.2396)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- O-Linked / Core 1
(avg mass : 383.3527)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 1
(avg mass : 512.4682)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 1
(avg mass : 674.6106)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 1
(avg mass : 674.6106)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 1
(avg mass : 965.8685)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 748.6901)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 828.7543)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 877.8056)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 1039.948)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 1081.0006)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 1161.0648)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 1186.091)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 1186.091)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 1227.1436)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 1331.2059)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 1332.234)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- O-Linked / Core 2
(avg mass : 1411.2701)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
-
- Hex:3 HexNAc:2 dHex:1 / N-Linked
(avg mass : 1056.9755)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GEVFNATR (8aa)
-
- Hex:3 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1463.3655)
- CHO (CVCL_0213)
- N-Linked / Complex / Structure 2643
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- Hex:6 HexNAc:2 Ph:1 / N-Linked
(avg mass : 1477.2396)
- CHO (CVCL_0213)
- N-Linked / High-Mannose / Structure 10092
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GEVFNATR (8aa)
-
- Hex:3 HexNAc:6 dHex:1 / N-Linked
(avg mass : 1869.7555)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1949.7927)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GEVFNATR (8aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GEVFNATR (8aa)
-
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2119.9608)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GEVFNATR (8aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2282.1032)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- Hex:5 HexNAc:5 dHex:3 / N-Linked
(avg mass : 2283.1313)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- Hex:6 HexNAc:7 / N-Linked
(avg mass : 2413.2347)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
- CHO (CVCL_0213)
- N-Linked / Complex / Structure 9815
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GEVFNATR (8aa)
-
- Hex:6 HexNAc:7 dHex:1 / N-Linked
(avg mass : 2559.3777)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
- GEVFNATR (8aa)
-
- Hex:7 HexNAc:7 dHex:1 / N-Linked
(avg mass : 2721.5201)
- CHO (CVCL_0213)
- N-Linked / Complex / Structure 10099
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GEVFNATR (8aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2809.583)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- Hex:8 HexNAc:8 dHex:1 / N-Linked
(avg mass : 3086.8575)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- Hex:10 HexNAc:9 dHex:1 / N-Linked
(avg mass : 3614.3373)
- CHO (CVCL_0213)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:10 HexNAc:9 dHex:1 / N-Linked
(avg mass : 3614.3373)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:8 HexNAc:8 dHex:1 / N-Linked
(avg mass : 3086.8575)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2809.583)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:7 dHex:1 / N-Linked
(avg mass : 2721.5201)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:7 dHex:1 / N-Linked
(avg mass : 2559.3777)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:7 / N-Linked
(avg mass : 2413.2347)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 dHex:3 / N-Linked
(avg mass : 2283.1313)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2282.1032)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2119.9608)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1949.7927)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:6 dHex:1 / N-Linked
(avg mass : 1869.7555)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:2 Ph:1 / N-Linked
(avg mass : 1477.2396)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1463.3655)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:2 dHex:1 / N-Linked
(avg mass : 1056.9755)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1411.2701)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1332.234)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1331.2059)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1227.1436)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1186.091)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1186.091)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1161.0648)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1081.0006)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1039.948)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 877.8056)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 828.7543)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 748.6901)
Source
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 965.8685)
Source
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 674.6106)
Source
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 674.6106)
Source
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 512.4682)
Source
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 383.3527)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / High-Mannose
(avg mass : 1477.2396)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 3248.9999)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2883.6625)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2721.5201)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2518.3251)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2444.2456)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2356.1827)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2194.0403)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2152.9877)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2031.8979)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1990.8453)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1828.7029)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1666.5605)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1625.5079)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1463.3655)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1422.3129)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1315.0972)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 1260.1705)
